BIO-THERA SOLUTIONS: COMPARABLE CLINICAL EFFICACY, SAFETY IN TREATMENT PERIOD 2 IS MAINTAINED AFTER SWITCH FROM REFERENCE TOCILIZUMAB TO TOFIDENCE
Reuters · 09/11 12:00
BIO-THERA SOLUTIONS: COMPARABLE CLINICAL EFFICACY, SAFETY IN TREATMENT PERIOD 2 IS MAINTAINED AFTER SWITCH FROM REFERENCE TOCILIZUMAB TO TOFIDENCE
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.